M Imad Damaj Selected Research

Edema (Dropsy)

1/2021	Deficit in voluntary wheel running in chronic inflammatory and neuropathic pain models in mice: Impact of sex and genotype.
11/2018	B-973, a Novel α7 nAChR Ago-PAM: Racemic and Asymmetric Synthesis, Electrophysiological Studies, and in Vivo Evaluation.
11/2015	The Antinociceptive and Antiinflammatory Properties of 3-furan-2-yl-N-p-tolyl-acrylamide, a Positive Allosteric Modulator of α7 Nicotinic Acetylcholine Receptors in Mice.
10/2015	The role of alpha5 nicotinic acetylcholine receptors in mouse models of chronic inflammatory and neuropathic pain.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

M Imad Damaj Research Topics

Disease

31	Pain (Aches) 05/2024 - 09/2003
27	Hyperalgesia 04/2024 - 03/2005
26	Tobacco Use Disorder (Nicotine Dependence) 04/2024 - 03/2005
15	Peripheral Nervous System Diseases (PNS Diseases) 11/2023 - 10/2015
13	Hypersensitivity (Allergy) 11/2023 - 01/2019
13	Neuralgia (Stump Neuralgia) 01/2023 - 08/2006
12	Inflammation (Inflammations) 05/2024 - 08/2006
11	Neoplasms (Cancer) 11/2023 - 11/2016
10	Hypothermia 11/2022 - 09/2003
9	Chronic Pain 11/2023 - 08/2006
5	Substance Withdrawal Syndrome (Withdrawal Symptoms) 01/2024 - 10/2018
5	Alcoholism (Alcohol Abuse) 01/2023 - 03/2013
4	Substance-Related Disorders (Drug Abuse) 11/2023 - 10/2011
4	Neuroinflammatory Diseases 01/2023 - 12/2020
4	Cold Hypersensitivity 12/2022 - 12/2020
4	Edema (Dropsy) 01/2021 - 10/2015
4	Acquired Immunodeficiency Syndrome (AIDS) 01/2019 - 06/2010
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2019 - 01/2018
3	Colitis 04/2017 - 09/2010
2	Breast Neoplasms (Breast Cancer) 11/2023 - 12/2020
2	Opioid-Related Disorders (Opiate Addiction) 01/2022 - 07/2021
2	Dyslipidemias (Dyslipidemia) 01/2021 - 12/2020
2	Binge Drinking 10/2019 - 01/2019
2	Anhedonia 01/2019 - 01/2017
2	Ovarian Neoplasms (Ovarian Cancer) 01/2018 - 01/2017
2	Mood Disorders (Mood Disorder) 01/2017 - 10/2015
2	Cocaine-Related Disorders (Cocaine Addiction) 01/2014 - 12/2010
2	Ulcerative Colitis 01/2013 - 09/2010
2	Acute Pain 09/2012 - 10/2004
2	Seizures (Absence Seizure) 09/2003 - 04/2003
1	Mental Disorders (Mental Disorder) 04/2024
1	Vitamin D Deficiency 11/2023

Drug/Important Bio-Agent (IBA)

46	Nicotine FDA Link 04/2024 - 04/2003
28	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 05/2024 - 04/2003
15	Paclitaxel (Taxol)FDA LinkGeneric 11/2023 - 11/2016
9	Morphine (MS Contin)FDA LinkGeneric 11/2023 - 01/2016
9	Formaldehyde (Formol)FDA Link 11/2022 - 09/2012
6	Opioid Analgesics (Opioids)IBA 10/2023 - 01/2016
6	Varenicline (Chantix)FDA Link 01/2018 - 12/2010
5	Analgesics (Analgesic Drugs)IBA 01/2021 - 09/2012
5	Cocaine (Cocaine HCl)IBA 01/2020 - 09/2003
5	Freund's AdjuvantIBA 01/2020 - 10/2015
5	Ethanol (Ethyl Alcohol)IBA 12/2019 - 03/2013
5	Bupropion (Wellbutrin)FDA LinkGeneric 01/2014 - 06/2010
4	Menthol FDA Link 03/2024 - 01/2015
4	Peptides (Polypeptides)IBA 11/2023 - 10/2004
4	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 12/2022 - 01/2017
4	Sucrose (Saccharose)IBA 01/2021 - 01/2017
4	LigandsIBA 01/2020 - 12/2010
4	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 12/2019 - 03/2011
3	Gabapentin (Neurontin)FDA LinkGeneric 11/2023 - 11/2016
3	Fenofibrate (CiL)FDA LinkGeneric 01/2021 - 01/2017
3	Choline (Choline Chloride)IBA 01/2021 - 01/2013
3	Acetic Acid (Vinegar)FDA LinkGeneric 01/2019 - 04/2015
3	MecamylamineIBA 01/2018 - 03/2005
3	1- (5- chloro- 2,4- dimethoxyphenyl)- 3- (5- methylisoxazol- 3- yl)ureaIBA 01/2018 - 01/2013
3	sodium sulfate (sodium bisulfate)FDA LinkGeneric 04/2017 - 09/2010
3	Dextrans (Dextran)FDA Link 04/2017 - 09/2010
3	CarrageenanIBA 11/2015 - 08/2006
3	cocaine- and amphetamine-regulated transcript protein (55-102)IBA 08/2006 - 09/2003
2	CytokinesIBA 12/2023 - 01/2020
2	Hypnotics and Sedatives (Sedatives)IBA 11/2023 - 04/2013
2	CalciumIBA 11/2023 - 01/2012
2	Volatile Fatty AcidsIBA 10/2023 - 05/2023
2	Butyric Acid (Butanoic Acid)IBA 10/2023 - 05/2023
2	Butyrates (Butyrate)IBA 10/2023 - 05/2023
2	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2012
2	CurcuminIBA 06/2022 - 10/2020
2	CannabinoidsIBA 01/2022 - 01/2018
2	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2022 - 01/2018
2	fenofibric acid FDA Link 01/2021 - 12/2020
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2021 - 01/2021
2	Cholinergic Agents (Cholinergics)IBA 01/2020 - 01/2013
2	SolutionsIBA 01/2020 - 04/2017
2	Antineoplastic Agents (Antineoplastics)IBA 10/2019 - 11/2016
2	4- (4- bromophenyl)- 3a,4,5,9b- tetrahydro- 3H- cyclopenta(c)quinoline- 8- sulfonamideIBA 01/2018 - 01/2016
2	1,4- diazabicyclo(3.2.2)nonan- 4- yl(5- (3- (trifluoromethyl)phenyl)furan- 2- yl)methanoneIBA 01/2018 - 04/2015
2	1- (5- chloro- 2- hydroxyphenyl)- 3- (2- chloro- 5- trifluoromethylphenyl)ureaIBA 01/2018 - 01/2013
2	CotinineIBA 06/2017 - 01/2013
2	Antidepressive Agents (Antidepressants)IBA 01/2014 - 06/2010
2	hydroxybupropionIBA 09/2010 - 06/2010
2	epibatidineIBA 03/2010 - 06/2006
2	Amphetamine (Amfetamine)FDA LinkGeneric 10/2004 - 09/2003
1	SaltsIBA 05/2024
1	nelotanserinIBA 04/2024
1	5-HT2A Serotonin Receptor (5 HT2A Receptor)IBA 04/2024
1	Therapeutic UsesIBA 01/2024
1	CannabidiolIBA 01/2024
1	Pregnenolone Carbonitrile (PCN)IBA 12/2023
1	ziconotide (Prialt)FDA Link 11/2023
1	PeptidomimeticsIBA 11/2023
1	N-Type Calcium Channels (N-Type Calcium Channel)IBA 11/2023
1	Calcium Channels (Calcium Channel)IBA 11/2023
1	Vitamin D FDA LinkGeneric 11/2023
1	theanineIBA 11/2023

Therapy/Procedure

18	Drug Therapy (Chemotherapy) 04/2024 - 07/2012
10	Therapeutics 05/2024 - 03/2006
5	Analgesia 11/2023 - 03/2005
4	Self Administration (Administration, Self) 01/2024 - 02/2011
2	Hypnosis (Mesmerism) 01/2018 - 03/2013